{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:11:07Z","timestamp":1791951067993,"version":"4.3.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Janssen-Cilag GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13011-018-0187-9","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T07:35:00Z","timestamp":1546500900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study"],"prefix":"10.1186","volume":"14","author":[{"given":"Lisa","family":"Strada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1999-2073","authenticated-orcid":false,"given":"Christiane Sybille","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Verthein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Scherbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"issue":"1","key":"187_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","volume":"106","author":"L Degenhardt","year":"2011","unstructured":"Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32\u201351.","journal-title":"Addiction"},{"key":"187_CR2","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2):CD002207.","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"187_CR3","volume-title":"WHO\/UNODC\/UNAIDS position paper : substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention","author":"WHO","year":"2004","unstructured":"WHO. WHO\/UNODC\/UNAIDS position paper : substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention. Geneva: World Health Organization, United Nations Office on Drugs and Crimes, UNAIDS; 2004."},{"issue":"12","key":"187_CR4","doi-asserted-by":"publisher","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","volume":"5","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, Grebely J, Dumchev KV, Griffiths P, Hines L, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Global Health. 2017;5(12):e1208\u201320.","journal-title":"Lancet Global Health"},{"issue":"12","key":"187_CR5","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, Stone J, Cunningham EB, Trickey A, Dumchev K, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Global Health. 2017;5(12):e1192\u2013207.","journal-title":"Lancet Global Health"},{"key":"187_CR6","unstructured":"UNODC. World Drug Report 2018 (United Nations publication, Sales No. E.18.XI.9). Booklet 4: Drugs and Age: United Nations; 2018."},{"key":"187_CR7","unstructured":"Ageing and addiction:challenges for treatment systems [\n                    http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/3435\/05_LXAddictions_AP_ageing_FINAL.pdf\n                    \n                  ]. Accessed 12 Dec 2008."},{"issue":"13","key":"187_CR8","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3109\/10826084.2015.1027929","volume":"50","author":"B Han","year":"2015","unstructured":"Han B, Polydorou S, Ferris R, Blaum CS, Ross S, McNeely J. Demographic Trends of Adults in New York City Opioid Treatment Programs\u2014An Aging Population. Subst Use Misuse. 2015;50(13):1660\u20137.","journal-title":"Subst Use Misuse"},{"issue":"11","key":"187_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3109\/01612840.2015.1081655","volume":"36","author":"A Searby","year":"2015","unstructured":"Searby A, Maude P, McGrath I. An Ageing Methadone Population: A Challenge to Aged Persons\u2019 Mental Health Services? Issues Ment Health Nurs. 2015;36(11):927\u201331.","journal-title":"Issues Ment Health Nurs"},{"issue":"6","key":"187_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/JGP.0b013e31816ff35a","volume":"16","author":"D Rosen","year":"2008","unstructured":"Rosen D, Smith ML, Reynolds CF 3rd. The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatr Psychiatry. 2008;16(6):488\u201397.","journal-title":"Am J Geriatr Psychiatry"},{"key":"187_CR11","doi-asserted-by":"publisher","first-page":"905368","DOI":"10.1155\/2013\/905368","volume":"2013","author":"D Rosen","year":"2013","unstructured":"Rosen D, Heberlein E, Engel RJ. Older adults and substance-related disorders: trends and associated costs. ISRN Addict. 2013;2013:905368.","journal-title":"ISRN Addict"},{"issue":"7","key":"187_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ijnurstu.2006.03.015","volume":"43","author":"P Moons","year":"2006","unstructured":"Moons P, Budts W, De Geest S. Critique on the conceptualisation of quality of life: a review and evaluation of different conceptual approaches. Int J Nurs Stud. 2006;43(7):891\u2013901.","journal-title":"Int J Nurs Stud"},{"issue":"5","key":"187_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1080\/10826080701204813","volume":"43","author":"M Astals","year":"2008","unstructured":"Astals M, Domingo-Salvany A, Buenaventura CC, Tato J, Vazquez JM, Martin-Santos R, Torrens M. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse. 2008;43(5):612\u201332.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"187_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.drugalcdep.2004.04.018","volume":"76","author":"DA Calsyn","year":"2004","unstructured":"Calsyn DA, Saxon AJ, Bush KR, Howell DN, Baer JS, Sloan KL, Malte CA, Kivlahan DR. The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. Drug Alcohol Depend. 2004;76(2):165\u201371.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"187_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3109\/10826084.2010.509854","volume":"46","author":"A Karow","year":"2011","unstructured":"Karow A, Verthein U, Pukrop R, Reimer J, Haasen C, Krausz M, Schafer I. Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence. Subst Use Misuse. 2011;46(6):705\u201315.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"187_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.drugalcdep.2010.06.009","volume":"112","author":"A Karow","year":"2010","unstructured":"Karow A, Reimer J, Schafer I, Krausz M, Haasen C, Verthein U. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence. Drug Alcohol Depend. 2010;112(3):209\u201315.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"187_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jsat.2006.11.009","volume":"33","author":"I Maremmani","year":"2007","unstructured":"Maremmani I, Pani PP, Pacini M, Perugi G. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat. 2007;33(1):91\u20138.","journal-title":"J Subst Abuse Treat"},{"issue":"7","key":"187_CR18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s11136-011-0027-0","volume":"21","author":"DW Raisch","year":"2012","unstructured":"Raisch DW, Campbell HM, Garnand DA, Jones MA, Sather MR, Naik R, Ling W. Health-related quality of life changes associated with buprenorphine treatment for opioid dependence. Qual Life Res. 2012;21(7):1177\u201383.","journal-title":"Qual Life Res"},{"issue":"2","key":"187_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/14659890500256945","volume":"11","author":"PJ Villeneuve","year":"2006","unstructured":"Villeneuve PJ, Challacombe L, Strike CJ, Myers T, Fischer B, Shore R, Hopkins S, Millson P. Change in health-related quality of life of opiate users in low-threshold methadone programs. J Subst Use. 2006;11(2):137\u201349.","journal-title":"J Subst Use"},{"issue":"12","key":"187_CR20","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1080\/10826080500260800","volume":"40","author":"J Bizzarri","year":"2005","unstructured":"Bizzarri J, Rucci P, Vallotta A, Girelli M, Scandolari A, Zerbetto E, Sbrana A, Iagher C, Dellantonio E. Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst Use Misuse. 2005;40(12):1765\u201376.","journal-title":"Subst Use Misuse"},{"issue":"6","key":"187_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3109\/10550490903205652","volume":"18","author":"PJ Carpentier","year":"2009","unstructured":"Carpentier PJ, Krabbe PF, van Gogh MT, Knapen LJ, Buitelaar JK, de Jong CA. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict. 2009;18(6):470\u201380.","journal-title":"Am J Addict"},{"key":"187_CR22","first-page":"227","volume":"13","author":"HU Wittchen","year":"2011","unstructured":"Wittchen HU, B\u00fchringer G, Rehm JT, Soyka M, Tr\u00e4der A, Trautmann S. The social, clinical and treatment situation of opioid maintenance treatment in a prevalence sample of patients at baseline. Suchtmedizin in Forschung und Praxis. 2011;13:227\u201337.","journal-title":"Suchtmedizin in Forschung und Praxis"},{"issue":"3","key":"187_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/00952990.2011.649222","volume":"38","author":"PW Wang","year":"2012","unstructured":"Wang PW, Wu HC, Yen CN, Yeh YC, Chung KS, Chang HC, Yen CF. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study. Am J Drug Alcohol Abuse. 2012;38(3):213\u20139.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"5","key":"187_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/00952990701523698","volume":"33","author":"AM Ponizovsky","year":"2007","unstructured":"Ponizovsky AM, Grinshpoon A. Quality of life among heroin users on buprenorphine versus methadone maintenance. Am J Drug Alcohol Abuse. 2007;33(5):631\u201342.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4-5","key":"187_CR25","first-page":"351","volume":"59","author":"B Habrat","year":"2002","unstructured":"Habrat B, Chmielewska K, Baran-Furga H, Keszycka B, Taracha E. Subjective Quality of Life in opiate-dependent patients before admission after six months and one-year participation in methadone program. Przeglad lekarski. 2002;59(4-5):351\u20134.","journal-title":"Przeglad lekarski"},{"issue":"Suppl 1","key":"187_CR26","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/QAI.0b013e318209754c","volume":"56","author":"PT Korthuis","year":"2011","unstructured":"Korthuis PT, Tozzi MJ, Nandi V, Fiellin DA, Weiss L, Egan JE, Botsko M, Acosta A, Gourevitch MN, Hersh D, et al. Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics. J Acquir Immune Defic Syndr (1999). 2011;56(Suppl 1):S39\u201345.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"2","key":"187_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000090426","volume":"12","author":"P Millson","year":"2006","unstructured":"Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, Shore R, Hopkins S. Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs. Eur Addict Res. 2006;12(2):74\u201382.","journal-title":"Eur Addict Res"},{"issue":"2-3","key":"187_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.drugalcdep.2006.06.012","volume":"86","author":"M Preau","year":"2007","unstructured":"Preau M, Protopopescu C, Spire B, Sobel A, Dellamonica P, Moatti JP, Carrieri MP. Health related quality of life among both current and former injection drug users who are HIV-infected. Drug Alcohol Dependence. 2007;86(2-3):175\u201382.","journal-title":"Drug Alcohol Dependence"},{"issue":"9","key":"187_CR29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1081\/JA-120039392","volume":"39","author":"E Puigdollers","year":"2004","unstructured":"Puigdollers E, Domingo-Salvany A, Brugal MT, Torrens M, Alvaros J, Castillo C, Magri N, Martin S, Vazquez JM. Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse. 2004;39(9):1353\u201368.","journal-title":"Subst Use Misuse"},{"issue":"11","key":"187_CR30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1089\/apc.2008.0005","volume":"22","author":"PT Korthuis","year":"2008","unstructured":"Korthuis PT, Zephyrin LC, Fleishman JA, Saha S, Josephs JS, McGrath MM, Hellinger J, Gebo KA. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDS. 2008;22(11):859\u201367.","journal-title":"AIDS Patient Care STDS"},{"key":"187_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.20882\/adicciones.594","volume":"11","author":"JF Miranda","year":"1999","unstructured":"Miranda JF, Ga- Portilla MG, Mart\u00ednez PS, Cienfuegos EG, Garc\u00eda JB. Calidad de vida y severidad de la adicci\u00f3n en heroin\u00f3manos en mantenimiento prolongado con metadona. Adicciones. 1999;11:43\u201352.","journal-title":"Adicciones"},{"issue":"4","key":"187_CR32","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1360-0443.2009.02509.x","volume":"104","author":"A Sch\u00e4fer","year":"2009","unstructured":"Sch\u00e4fer A, Wittchen HU, Backmund M, Soyka M, Golz J, Siegert J, Schafer M, Tretter F, Kraus MR. Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy. Addiction (Abingdon, England). 2009;104(4):630\u201340.","journal-title":"Addiction (Abingdon, England)"},{"key":"187_CR33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12879-015-1307-z","volume":"15","author":"L Strada","year":"2015","unstructured":"Strada L, Schulte B, Schmidt CS, Verthein U, Cremer-Schaeffer P, Kruckeberg S, Reimer J. Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol. BMC Infect Dis. 2015;15:563.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"187_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jclinepi.2004.06.005","volume":"58","author":"TV Perneger","year":"2005","unstructured":"Perneger TV, Burnand B. A simple imputation algorithm reduced missing data in SF-12 health surveys. J Clin Epidemiol. 2005;58(2):142\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"187_CR35","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0895-4356(98)00109-7","volume":"51","author":"B Gandek","year":"1998","unstructured":"Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171\u20138.","journal-title":"J Clin Epidemiol"},{"key":"187_CR36","volume-title":"SF-36 Fragebogen zum Gesundheitszustand: Deutsche Version des Short Form-36 Health Survey","author":"M Morfeld","year":"2011","unstructured":"Morfeld M, Kirchberger I, Bullinger M. SF-36 Fragebogen zum Gesundheitszustand: Deutsche Version des Short Form-36 Health Survey; 2011."},{"issue":"3","key":"187_CR37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333.","journal-title":"Med Care"},{"issue":"6846","key":"187_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","volume":"305","author":"JE Brazier","year":"1992","unstructured":"Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160\u20134.","journal-title":"BMJ"},{"key":"187_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jsat.2017.01.019","volume":"76","author":"JW Bray","year":"2017","unstructured":"Bray JW, Aden B, Eggman AA, Hellerstein L, Wittenberg E, Nosyk B, Stribling JC, Schackman BR. Quality of life as an outcome of opioid use disorder treatment: A systematic review. J Subst Abuse Treat. 2017;76:88\u201393.","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"187_CR40","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.drugpo.2010.01.010","volume":"21","author":"J Maeyer De","year":"2010","unstructured":"De Maeyer J, Vanderplasschen W, Broekaert E. Quality of life among opiate-dependent individuals: A review of the literature. Int J Drug Policy. 2010;21(5):364\u201380.","journal-title":"Int J Drug Policy"},{"key":"187_CR41","unstructured":"Derogatis LR. Brief Symptom Inventory: BSI; Administration, scoring, and procedures manual. Minneapolis: National Computer Systems; 1993."},{"issue":"5","key":"187_CR42","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1360-0443.1992.tb02719.x","volume":"87","author":"S Darke","year":"1992","unstructured":"Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992;87(5):733\u201342.","journal-title":"Br J Addict"},{"issue":"10","key":"187_CR43","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1360-0443.1991.tb01707.x","volume":"86","author":"S Darke","year":"1991","unstructured":"Darke S, Ward J, Zador D, Swift G. A scale for estimating the health status of opioid users. Br J Addict. 1991;86(10):1317\u201322.","journal-title":"Br J Addict"},{"key":"187_CR44","unstructured":"APA. American Psychiatric Association (APA): Diagnostic and statistical manual of mental disorders (DSM-IV). In: 4th. Washington, DC: American Psychiatric Publishing; 1994."},{"key":"187_CR45","unstructured":"Guy W: The clinical global impression scale. The ECDEU assessment manual for psychopharmacology revised, vol. DHEW. Rockvillee, MD: US Department of Health, Education, and Welfare. Public Health Service, Alcohol, Drug Abuse, Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research.; 1976."},{"issue":"5","key":"187_CR46","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1037\/a0015808","volume":"40","author":"CJ Ferguson","year":"2009","unstructured":"Christopher J. Ferguson, (2009) An effect size primer: A guide for clinicians and researchers. Professional Psychology: Research and Practice 40 (5):532\u2013538.","journal-title":"Professional Psychology: Research and Practice"},{"key":"187_CR47","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2147\/PPA.S49113","volume":"7","author":"V Mravcik","year":"2013","unstructured":"Mravcik V, Strada L, Stolfa J, Bencko V, Groshkova T, Reimer J, Schulte B. Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review. Patient Prefer Adherence. 2013;7:1067\u201375.","journal-title":"Patient Prefer Adherence"},{"issue":"27","key":"187_CR48","doi-asserted-by":"publisher","first-page":"e4061","DOI":"10.1097\/MD.0000000000004061","volume":"95","author":"B Scheiner","year":"2016","unstructured":"Scheiner B, Schwabl P, Steiner S, Bucsics T, Chromy D, Aichelburg MC, Grabmeier-Pfistershammer K, Trauner M, Peck-Radosavljevic M, Reiberger T, et al. Interferon-free regimens improve health-related quality of life and fatigue in HIV\/HCV-coinfected patients with advanced liver disease: A retrospective study. Medicine. 2016;95(27):e4061.","journal-title":"Medicine"},{"key":"187_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12879-015-0748-8","volume":"15","author":"J Smith-Palmer","year":"2015","unstructured":"Smith-Palmer J, Cerri K, Valentine W. Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits. BMC Infect Dis. 2015;15:19.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"187_CR50","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1590\/S1413-81232013000700010","volume":"18","author":"C Moreira Tde","year":"2013","unstructured":"Moreira Tde C, Figueiro LR, Fernandes S, Justo FM, Dias IR, Barros HM, Ferigolo M. Quality of life of users of psychoactive substances, relatives, and non-users assessed using the WHOQOL-BREF. Cien Saude Colet. 2013;18(7):1953\u201362.","journal-title":"Cien Saude Colet"},{"issue":"1","key":"187_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/eurpub\/11.1.109","volume":"11","author":"MJ Vaarwerk te","year":"2001","unstructured":"te Vaarwerk MJ, Gaal EA. Psychological distress and quality of life in drug-using and non-drug-using HIV-infected women. Eur J Public Health. 2001;11(1):109\u201315.","journal-title":"Eur J Public Health"},{"issue":"1","key":"187_CR52","first-page":"1","volume":"22","author":"N Fingleton","year":"2015","unstructured":"Fingleton N, Matheson C, Jaffray M. Changes in mental health during opiate replacement therapy: A systematic review. Drugs: Education, Prevention and Policy. 2015;22(1):1\u201318.","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"187_CR53","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1192\/bjp.176.3.285","volume":"176","author":"J Marsden","year":"2000","unstructured":"Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry. 2000;176:285\u20139.","journal-title":"Br J Psychiatry"},{"key":"187_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.05.031","volume":"154","author":"HM Lai","year":"2015","unstructured":"Lai HM, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:1\u201313.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"187_CR55","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.eurpsy.2010.10.001","volume":"27","author":"V Reissner","year":"2012","unstructured":"Reissner V, Kokkevi A, Schifano F, Room R, Storbjork J, Stohler R, DiFuria L, Rehm J, Geyer M, Holscher F, et al. Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project). Eur Psychiatry. 2012;27(6):455\u201362.","journal-title":"Eur Psychiatry"},{"issue":"2","key":"187_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000468518","volume":"23","author":"M Soyka","year":"2017","unstructured":"Soyka M, Strehle J, Rehm J, Buhringer G, Wittchen HU. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample. Eur Addiction Res. 2017;23(2):97\u2013105.","journal-title":"Eur Addiction Res"},{"issue":"3","key":"187_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1108\/ADD-02-2014-0007","volume":"7","author":"N Ottar","year":"2014","unstructured":"Ottar N, Marit B, Larry D. Facilitators and barriers in dual recovery: a literature review of first-person perspectives. Adv Dual Diagnosis. 2014;7(3):107\u201317.","journal-title":"Adv Dual Diagnosis"},{"key":"187_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","volume":"61","author":"MA Priester","year":"2016","unstructured":"Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD. Treatment Access Barriers and Disparities Among Individuals with Co-Occurring Mental Health and Substance Use Disorders: An Integrative Literature Review. J Subst Abuse Treat. 2016;61:47\u201359.","journal-title":"J Subst Abuse Treat"},{"key":"187_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1747-597X-8-26","volume":"8","author":"B Schulte","year":"2013","unstructured":"Schulte B, Schmidt CS, Kuhnigk O, Schafer I, Fischer B, Wedemeyer H, Reimer J. Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care. Subst Abuse Treat Prev Policy. 2013;8:26.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"3","key":"187_CR60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.drugalcdep.2010.06.013","volume":"112","author":"FJ Eiroa-Orosa","year":"2010","unstructured":"Eiroa-Orosa FJ, Haasen C, Verthein U, Dilg C, Schafer I, Reimer J. Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial. Drug Alcohol Depend. 2010;112(3):226\u201333.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"187_CR61","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M. Benzodiazepines revisited--will we ever learn? Addiction (Abingdon, England). 2011;106(12):2086\u2013109.","journal-title":"Addiction (Abingdon, England)"},{"key":"187_CR62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drugalcdep.2014.06.020","volume":"142","author":"F Lugoboni","year":"2014","unstructured":"Lugoboni F, Mirijello A, Faccini M, Casari R, Cossari A, Musi G, Bissoli G, Quaglio G, Addolorato G. Quality of life in a cohort of high-dose benzodiazepine dependent patients. Drug Alcohol Depend. 2014;142:105\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"187_CR63","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.comppsych.2013.12.007","volume":"55","author":"D Caldirola","year":"2014","unstructured":"Caldirola D, Grassi M, Riva A, Dacco S, De Berardis D, Dal Santo B, Perna G. Self-reported quality of life and clinician-rated functioning in mood and anxiety disorders: relationships and neuropsychological correlates. Compr Psychiatry. 2014;55(4):979\u201388.","journal-title":"Compr Psychiatry"},{"issue":"12","key":"187_CR64","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/da.21993","volume":"29","author":"R Uher","year":"2012","unstructured":"Uher R, Perlis RH, Placentino A, Dernovsek MZ, Henigsberg N, Mors O, Maier W, McGuffin P, Farmer A. Self-report and clinician-rated measures of depression severity: can one replace the other? Depress Anxiety. 2012;29(12):1043\u20139.","journal-title":"Depress Anxiety"},{"issue":"1","key":"187_CR65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11469-017-9784-5","volume":"16","author":"H Dauber","year":"2018","unstructured":"Dauber H, Braun B, Pfeiffer-Gerschel T, Kraus L, Pogarell O. Co-occurring Mental Disorders in Substance Abuse Treatment: the Current Health Care Situation in Germany. Int J Mental Health Addict. 2018;16(1):66\u201380.","journal-title":"Int J Mental Health Addict"},{"issue":"1","key":"187_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.addbeh.2009.08.003","volume":"35","author":"J Wang","year":"2010","unstructured":"Wang J, Kelly BC, Booth BM, Falck RS, Leukefeld C, Carlson RG. Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users. Addict Behav. 2010;35(1):23\u20139.","journal-title":"Addict Behav"},{"key":"187_CR67","unstructured":"DHS: German Centre for Addiction Issues (DHS, Deutsche Hauptstelle f\u00fcr Suchtfragen): Suchthilfe und Versorgungssituation in Deutschland. Retrieved from: \n                    http:\/\/www.dhs.de\/fileadmin\/user_upload\/pdf\/dhs_stellungnahmen\/2014-08-27_DHS-Systemanalyse_Finale_01.pdf\n                    \n                   2014. Accessed 12 Dec 2008."},{"issue":"5-6","key":"187_CR68","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00103-013-1700-y","volume":"56","author":"U Ellert","year":"2013","unstructured":"Ellert U, Kurth BM. Health related quality of life in adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2013;56(5-6):643\u20139.","journal-title":"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz"},{"key":"187_CR69","unstructured":"DESTATIS: German Federal Statistical Office (DESTATIS, Statistisches Bundesamt). Bev\u00f6lkerungsstand \u2013 Durchschnittsalter nach Geschlecht und Staatsangeh\u00f6rigkeit. 2018. Retreived from: \n                    https:\/\/www.destatis.de\/DE\/ZahlenFakten\/GesellschaftStaat\/Bevoelkerung\/Bevoelkerungsstand\/Tabellen\/Durchschnittsalter_Zensus.html\n                    \n                  . Accessed 12 Dec 2008."},{"issue":"Sonderheft 2","key":"187_CR70","first-page":"S184","volume":"61","author":"U Ellert","year":"1999","unstructured":"Ellert U, Bellach BM. Der SF-36 im Bundes-Gesundheitssurvey \u2013 Beschreibung einer aktuellen Normstichprobe. Gesundheitswesen. 1999;61(Sonderheft 2):S184\u201390.","journal-title":"Gesundheitswesen"},{"issue":"5","key":"187_CR71","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000484239","volume":"23","author":"L Strada","year":"2017","unstructured":"Strada L, Franke GH, Schulte B, Reimer J, Verthein U. Development of OSTQOL: A Measure of Quality of Life for Patients in Opioid Substitution Treatment. Eur Addict Res. 2017;23(5):238\u201348.","journal-title":"Eur Addict Res"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-018-0187-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13011-018-0187-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-018-0187-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T19:27:59Z","timestamp":1577993279000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-018-0187-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["187"],"URL":"https:\/\/doi.org\/10.1186\/s13011-018-0187-9","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"10 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was granted by the Ethics Committee of the Medical Association of Hamburg, Ref. PV4603, and by each local Ethics Committee in Germany.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; no details on individuals are reported within the manuscript","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JR received unrestricted educational grants, adviser and\/or speakers remuneration from AbbVie, Desitin, Gilead, Janssen-Cilag, Mundipharma, Otsuka-Lundbeck, Hexal.NS received honoraria for several activities (advisory boards, lectures, manuscripts and educational material) by the factories AbbVie, Lundbeck, Medice, Mundipharma, Reckitt-Benckiser\/Indivior, and Sanofi-Aventis. During the last three years he participated in clinical trials financed by the pharmaceutical industry.BS, UV, LS, CS, MR declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"2"}}